Propranolol for severe infantile hemangiomas: follow-up report.
about
Cutaneous lesions of the noseBeta-blockers for prevention and treatment of retinopathy of prematurity in preterm infantsCardiovascular drugs in the treatment of infantile hemangiomaPropranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapyRepurposing of approved cardiovascular drugsStudy protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau diseaseKasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literatureSafety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Successful treatment of mild pediatric kasabach-merritt phenomenon with propranolol monotherapyManagement of periorbital hemangioma by intralesional glucocorticoids and systemic propranolol: a single-center retrospective studyDeveloping a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model.Beta-blockers as therapy for infantile hemangiomasEffects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitroInfantile haemangioma: part II. Risks, complications and treatment.Hemangiomas revisited: the useful, the unusual and the new. Part 2: endangering hemangiomas and treatment.Periocular capillary hemangiomas: indications and options for treatment.Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.Management of infantile hemangiomas: current trendsTopical propranolol therapy for infantile hemangiomas.The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.Propranolol therapy for infantile hemangioma is less toxic but longer in duration than corticosteroid therapy.Biology of infantile hemangiomaInfantile hemangioma in a v2 distribution: treatment with nadololHaemangioma of infancy: two case reports with an overdose of propranolol.The use of propranolol in the management of periocular capillary haemangioma--a systematic reviewPulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis.Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from oman.Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9Hemangioma treatment with pulsed dye laser-distinct parameters used between neonatal and non-neonatal patients.Propranolol: Effectiveness and Failure in Infantile Cutaneous HemangiomasPropranolol treatment for infantile hemangioma does not increase risk of childhood wheezing.Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studiesPropranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase RegulationA prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma.β-blockers: a novel class of antitumor agents.
P2860
Q21203651-90F6BD27-EDF1-40B1-AF09-FC3A3751898DQ24187442-CF8F6BC2-AA90-4A18-8702-4FFA020C26AAQ26769978-5D0C5780-AA38-4309-9658-396733279696Q27005682-3794D4CA-881E-4ECE-9870-4DA04738A90DQ28074453-8ACB5E1B-346C-416C-8332-26AD8EA19C4BQ30992212-AFD92BA8-5A20-402D-9CE7-BA22B75BC987Q32174211-11CEFE8E-7098-424E-BB37-0CB0EE5A2C02Q33425445-F59B329F-B6A1-434A-B61D-07EF4D0FACBDQ33577048-FDEC298C-0080-413C-9780-CED5E74C8ED1Q33745400-190EE524-F2CC-4299-B72C-B97D88C4E574Q33756270-ED77937A-FF57-43B3-A371-8CB0708D68F4Q33802563-A7961F36-33A9-496A-A63F-7B5CC37103DFQ33832594-32BEEA96-5684-4785-86B4-32B3C9AABEFFQ33837509-9C4434E5-1279-4781-AA5B-84534B547898Q33898263-DF2E3CB1-996B-417E-9AAB-63EEDA0A6F50Q33909972-C25D6378-49A2-44C4-840B-84CAF89E8CD7Q33941063-86C816CC-3B50-4307-9AD1-503D819C7274Q34034894-FC70647A-C937-4769-988E-100AA952C06CQ34052390-2542EB5F-8991-4E6D-A30B-7E02490F217BQ34091598-0DE4FCA4-9F1F-4A60-863D-DE88D77630B1Q34209504-D716F10E-9C65-434B-899A-B3D7DB70CAA5Q34742712-6C2ED747-CFFD-487C-BF36-CA16625D0865Q34867993-DA0EEF8E-319C-4C76-A582-3FD9EC147B22Q35198657-A0AB77D6-FE04-4780-9BA3-B4D3A520FE8EQ35219212-C66ECBA4-0AE7-4569-9188-7C97140DF592Q35358798-F20FD953-39BC-48DB-B8A0-45A1149E284AQ35400742-30C3259B-B252-4B3D-963B-664176C2427BQ35603555-27080942-3BEB-4C96-9F70-2AB794D8F2A4Q35646495-86B59DFE-087D-42A4-81AD-D0D3D7A65D27Q35777099-DEE6ADE7-04AC-4DBD-B0CC-6574DE994F40Q35803457-A1379016-042A-440A-94B4-04C88B630D16Q35851345-80402E1E-9104-4F6D-B131-9A90F474B69CQ35942857-56566DF3-1B44-48A5-A263-106ED2575ABAQ36058730-35B8F4C8-BA0A-4E57-9A3E-765853ED59C0Q36164771-F6E724FB-98AF-46FE-9943-0637B681DC21Q36299241-698B1C7E-D5A5-458A-9238-78D9F1C74CACQ36310708-D8F949DD-C0E8-4C37-8054-69CD6F2FAD87Q36440738-5D8C2648-7D2D-489E-9856-DFE92846FCC2Q36442155-F7C07318-4688-47FC-A53F-A6ADBFC3E0F0Q36443830-AFBBC655-EDF1-4DF3-8A48-7E50B78BAD06
P2860
Propranolol for severe infantile hemangiomas: follow-up report.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Propranolol for severe infantile hemangiomas: follow-up report.
@en
Propranolol for severe infantile hemangiomas: follow-up report.
@nl
type
label
Propranolol for severe infantile hemangiomas: follow-up report.
@en
Propranolol for severe infantile hemangiomas: follow-up report.
@nl
prefLabel
Propranolol for severe infantile hemangiomas: follow-up report.
@en
Propranolol for severe infantile hemangiomas: follow-up report.
@nl
P2093
P356
P1433
P1476
Propranolol for severe infantile hemangiomas: follow-up report.
@en
P2093
Alain Taïeb
Christine Léauté-Labrèze
Dan Lipsker
Elisabeth Dupuis
Eric Dumas de la Roque
Juliette Mazereeuw-Hautier
Jérôme Berge
Nicolas Grenier
Pierre Vergnes
Véronique Sans
P304
P356
10.1542/PEDS.2008-3458
P407
P577
2009-08-10T00:00:00Z